Æ÷½ºÅÍ : ¸ðüžÆÀÇÇÐ |
- ÀϽà : 2014³â 9¿ù 26ÀÏ(±Ý) ~ 2014³â 9¿ù 27ÀÏ(Åä)
- Àå¼Ò : EXHIBITION HALL B[1F] |
(08:00~14:00) |
ÁÂÀå : |
1-OB108:00~08:06 |
°À±´Ü ´Ü±¹´ëÇб³º´¿ø »êºÎÀΰú |
Profiles of tight junction, integrin beta1 and adhesion proteins in patients with preterm premature rupture of the membrane |
2-OB208:06~08:12 |
°íÁ¤È °¿ø´ëÇб³º´¿ø »êºÎÀΰú |
°íÁÖÆÄ ÀڱñÙÁ¾¿ëÇؼú ÈÄ ÀÓ½Å3ºÐ±â ÁøÅë¾øÀÌ ¹ß»ýÇÑ ÀÚ¿¬ÀÚ±ÃÆÄ¿ 1¿¹ |
3-OB308:12~08:18 |
°íÇö¼± °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
±¹¹Î°Ç°¿µ¾çÁ¶»ç (2010-2012)¿¡ µû¸¥ ºÐ¸¸·Â°ú Áß³âÀÌÈÄ °ñ°üÀý¿°°úÀÇ ¿¬°ü°ü°è¿¡ ´ëÇÑ ¿¬±¸ |
4-OB408:18~08:24 |
±ÇÇÏ¾á ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Maternal serum pregnancy-associated plasma protein-A as a predictor of severe preeclampsia
|
5-OB508:24~08:30 |
±è°æ¼ ÁÁÀº¹®Èº´¿ø »êºÎÀΰú |
Placenta increta diagnosed in the first trimester of pregnancy rescued by methotrexate (MTX) therapy: a case report |
6-OB608:30~08:36 |
±è¹Ì¼± ÀÎÁ¦ÀÇ´ë »ó°è¹éº´¿ø »êºÎÀΰú |
ÀÀ±Þ Á¦¿ÕÀý°³¼ú¿¡¼ÀÇ ¼ö¼ú °áÁ¤-Àý°³ ½Ã°£¿¡ µû¸¥ ½Å»ý¾Æ ¿¹ÈÄ ÀÎÀÚÀÇ º¯È |
7-OB708:36~08:42 |
±è¹Ì¿µ Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú |
Single institute experience, success rate and obstetric outcomes after external cephalic version at term. |
8-OB808:42~08:48 |
±è¼º¹Ì °è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú |
ÀӽŠÁ¦2ºÐ±â¿¡ Áø´ÜµÈ ÅÂ¾Æ µÎ°³ ³» ±âÇüÁ¾ |
9-OB908:48~08:54 |
±è¼¼·Ã ±×·¹À̽ºº´¿ø |
»ê¸ðÀÇ ºñŸ¹Î D °áÇÌ°ú »êÀü°ü¸®: »êºÎÀΰú Àü¹®º´¿øÀÇ °æÇè |
10-OB1008:54~09:00 |
±è¼ö¹Ì ´Ü±¹´ëÇб³º´¿ø »êºÎÀΰú |
Maternal hypotension induced by regional anesthesia for elective cesarean section:
Risk factors and the effect of short-term neonatal outcome
|
11-OB1109:00~09:06 |
±èÁ¾ÀÎ °è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú |
A successful term delivery with maternal diaphragmatic hernia
|
12-OB1209:06~09:12 |
±èÁ¾ÀÎ °è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú |
Outcomes of emergency or physical examination-indicated cerclage in twin pregnancies compared to singleton pregnancies
|
13-OB1309:12~09:18 |
±èÁ¾ÀÎ °è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú |
Outcomes of twin pregnancies with single fetal death:
management, maternal and fetal outcome.
|
14-OB1409:18~09:24 |
±èÁ¾ÀÎ °è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú |
A case of abrupt onset postpartum HELLP syndrome
without antepartum pregnancy induced hypertension
|
15-OB1509:24~09:30 |
±èÁöÇý ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
Hepatic infarction in pregnant woman with antiphospholipid syndrome : a case report |
16-OB1609:30~09:36 |
±èÇö°æ °¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø »êºÎÀΰú |
A Case of Myelodysplastic Syndrome in Pregnancy combined with HELLP Syndrome |
17-OB1709:36~09:42 |
±èÇý¼º ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
ÀӽŠÃʱ⿡ ¹«Áõ»ó °©»ó¼±±â´ÉÀúÇÏÁõÀÇ Áø´ÜÀ» À§ÇÑ ÁÖ¼öº° ±âÁØÀÌ ÇÊ¿äÇÑ°¡?
-Çѱ¹ ÀӽŠ¿©¼º¿¡¼ ÀӽŠ1ºÐ±â ÁÖ¼öº° TSHÀÇ ³óµµ |
18-OB1809:42~09:48 |
¹®´ÙÇö Àü³²´ëÇб³º´¿ø »êºÎÀΰú |
Uterine artery pseudoaneurysm manifesting as delayed postpartum hemorrhage after precipitous delivery: three case reports |
19-OB1909:48~09:54 |
¹®¿©Á¤ ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
The effect of hypoxia on the placental productions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1 in villous explants from normal pregnancy and preeclampsia |
20-OB2009:54~10:00 |
¹ÎÀ翵 °¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú |
Selective angiographic embolization of an infralevator vulvovaginal hematoma after birth: Case report |
21-OB2110:00~10:06 |
¹Ú¹Î¿µ Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú |
Frontal lobe and cerebellar differences in IUGR and AGA fetuses. |
22-OB2210:06~10:12 |
¹ÚÁöÀ± ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
A case of successful vaginal birth after prior cesarean section in a patient with pyoderma gangrenosum |
23-OB2310:12~10:18 |
¹ÚÈ¿°æ ¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú |
Posterior sacculation of the uterus with uterine fibroid in a patient presenting with lower
abdominal pain at 33 weeks of gestation |
24-OB2410:18~10:24 |
¼®Áø¼÷ °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA) syndrome: Prenatal Sonographic Detection |
25-OB2510:24~10:30 |
¼Û¼ö¿¬ Ãæ³²´ëÇб³º´¿ø »êºÎÀΰú |
Uterine scar dehiscence after laparoscopic myomectomy |
26-OB2610:30~10:36 |
½ÅÀ¯Á¤
|
Genome-wide microRNA expression profiling in fetal trisomy 21 placenta |
27-OB2710:36~10:42 |
½ÅÀçÀº °¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø »êºÎÀΰú |
Case report: Successful hysteroscopic removal of cesarean scar pregnancy after embolization |
28-OB2810:42~10:48 |
½ÅÁ¤±Ô °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
Up-regulation of O-GlcNAc transferas (OGT) mRNA in human preeclamptic placenta tussues |
29-OB2910:48~10:54 |
¾È±âÈÆ °í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú |
Current status of planned pregnancy in Korean women |
30-OB3010:54~11:00 |
¾È±âÈÆ °í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú |
A Novel cell therapy source for preterm premature rupture of membrane using amnionic epithelial stem cells: Preliminary study |
31-OB3111:00~11:06 |
¾È±âÈÆ °í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú |
Lateral ventricular width of fetal brain is associated with maternal blood glucose level |
32-OB3211:06~11:12 |
¾ÈÅÂ±Ô ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
µÎ À¶¸ð¸·¼º ½ÖÅÂ¾Æ Àӽſ¡¼ Ãʱâ CRLÂ÷ÀÌ¿Í Ãâ»ýüÁßÂ÷ÀÌ¿ÍÀÇ ¿¬°ü¼º |
33-OB3311:12~11:18 |
¾ç¼±¿µ °í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú |
A Case of Prolapsed submucosal leiomyoma after normal delivery |
34-OB3411:18~11:24 |
¾ç¿ëÀç ÀÎõ±âµ¶º´¿ø »êºÎÀΰú |
High-intensity focused ultrasound combined with hysteroscopic resection to treat retained placenta accreta : A Case Report
|
35-OB3511:24~11:30 |
¾çÁÖ¼® ¾ç»êºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú |
Bilateral rupture of the renal pelvis as a complication of placental abruption in multiparous female |
36-OB3611:30~11:36 |
¿¬ÁöÈñ Ãæ³²´ëÇб³º´¿ø »êºÎÀΰú |
»êÀü ¾ç¼ö³» ¾Æ¼¼Æ¿Äݸ°¿¡½ºÅͶóÁ¦ ¾ç¼º ¼Ò°ß žƿ¡¼ Ãâ»êÈÄ ¹ß°ßµÈ Incontinentia pigmentia 1¿¹ |
37-OB3711:36~11:42 |
¿À¼ö¿µ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
Inhibition of autophagy enhances trophoblast invasion by affecting cell-to-cell junctions
|
38-OB3811:42~11:48 |
À¯½½±â ¿ï»ê´ëÇб³º´¿ø »êºÎÀΰú |
Mirror Syndrome associated with fetal leukemia |
39-OB3911:48~11:54 |
À±°¡¿µ ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú |
A case of amniotic fluid embolism
|
40-OB4011:54~12:00 |
À±ÇýÁ¤ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Isolation and Characterization of Chorionic Mesenchymal
Stromal Cells from Human Full Term Placenta |
41-OB4112:00~12:06 |
ÀÌ°æ¾Æ °æÈñÀÇ´ë °æÈñÀÇ·á¿ø »êºÎÀΰú |
º´ÀûÀÚ±Ã°í¸®(Pathologic uterine ring)ÀÇ Á¶±â ¹ßÇöÀ¸·Î ÀÎÇÑ Áö¼ÓÀû žÆÀÚ¼¼ÀÌ»ó°ú ÁÖ»ê±â¿¹ÈÄ |
42-OB4212:06~12:12 |
ÀÌ¹Î°æ °¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú |
Maternal and fetal morbidities in perinatal measles infection: A case report |
43-OB4312:12~12:18 |
À̽ÂÁ¤ °æºÏ´ëÇб³º´¿ø »êºÎÀΰú |
Heterotopic pregnancy after transfer of a single embryo |
44-OB4412:18~12:24 |
ÀÌ¿µÁÖ ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú |
The torsion of paratubal cyst during pregnancy |
45-OB4512:24~12:30 |
ÀÌÀ¯¼± ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Medical treatment with danazol of uterine arteriovenous malformation: a case series of 12 patients |
46-OB4612:30~12:36 |
ÀÌÀ±°æ °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
Chromosome 18p deletion syndrome presenting holoprosencephaly diagnosed prenatally |
47-OB4712:36~12:42 |
ÀÌÁö¼± ¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú |
Perinatal outcomes of selective and non-selective intrauterine growth restriction in twin
pregnancy |
48-OB4812:42~12:48 |
ÀÌÁö¿¬ ¿ï»ê´ëÇб³º´¿ø »êºÎÀΰú |
A study on the postpartum symptoms and their related factors in Korea |
49-OB4912:48~12:54 |
ÀÌÅÂÈ °í½ÅÀÇ´ë º¹À½º´¿ø »êºÎÀΰú |
A case of Antiphospholipid Syndrome with hemolytic anemia during pregnancy: Review of the Literature |
50-OB5012:54~13:00 |
ÀÌÇý³² Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Assessment of intracranial translucency at 11+0 to 13+6 weeks scan in a Korean population |
51-OB5113:00~13:06 |
ÀÌÈ¿·Ã ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
The factors associated with the failure of pelvic artery embolization for postpartum hemorrhage: results from a single tertiary referral center |
52-OB5213:06~13:12 |
ÀÓ¼±È Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú |
Fatal death: Cord accident in late pregnancy |
53-OB5313:12~13:18 |
ÀåÁö¾Ö ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø »êºÎÀΰú |
¸·¾çºÎÂøÀÌ µ¿¹ÝµÈ ÅÂ¾Æ ³» Á¦´ë Á¤¸ÆÀÇ Á¤¸Æ·ù 1¿¹ |
54-OB5413:18~13:24 |
Á¤À±Áö ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Pregnancy outcome in women with Moyamoya disease : a single-center experience in Korea |
55-OB5513:24~13:30 |
Á¶±ÝÁØ °í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú |
The altered vascular reactivity in offspring from pregnant mice model of preeclampsia |
56-OB5613:30~13:36 |
Á¶¹Î°æ ¼øõÇâÀÇ´ë õ¾Èº´¿ø »êºÎÀΰú |
The Safety of thromboprophylaxis soon after surgery with low molecular weight heparins in high risk women undergoing cesarean section |
57-OB5713:36~13:42 |
Á¶À±Áø °¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú |
2 cases of acute pancreatitis during pregnancy associated hypertriglyceridemia and gallstone |
58-OB5813:42~13:48 |
Á¶ÀÎ¾Ö °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
Stepwise Conservative Management of Postpartum Hemorrhage Due to Placenta Previa Accreta during Cesarean Delivery |
59-OB5913:48~13:54 |
Â÷ÇöÈ °æºÏ´ëÇб³º´¿ø »êºÎÀΰú |
The upper cutoff values of 50-g glucose challenge test that can omit 100-g glucose tolerance test according to NDDG and Carpenter and Coustan criteria. |
60-OB6013:54~14:00 |
ÃÖº´Èñ ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú |
Huge size theca luteal cyst in normal pregnancy : A Case Report |
61-OB6114:00~14:06 |
ÃÖ¼¼°æ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Is IOM recommendations for gestational weight gain proper for Korean women? |
62-OB6214:06~14:12 |
ŹÁö¿µ °æºÏ´ëÇб³º´¿ø »êºÎÀΰú |
Spontaneous restoration of missed uterine inversion |
63-OB6314:12~14:18 |
ÇÑÁ¤¿
|
Positive effects of Teratogenic risk counseling in pregnant women
inadvertently exposed to medications
|
64-OB6414:18~14:24 |
È£Á¤±Ô ÇѾç´ëÇб³º´¿ø »êºÎÀΰú |
Nonlinear analysis of fetal heart rate dynamics in fetuses compromised by maternal systemic lupus erythematosus |
65-OB6514:24~14:30 |
È£Á¤±Ô ÇѾç´ëÇб³º´¿ø »êºÎÀΰú |
Prediction of low birth weight infants with nonlinear dynamic indices in the third trimester of pregnancy: a comparison of support vector machines and multiple logistic regression models |
ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ |
- ÀϽà : 2014³â 9¿ù 26ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F] |
OB1-OB4 (08:20~09:00) |
ÁÂÀå : ½ÅÁ¾Ã¶(°¡Å縯ÀÇ´ë) |
OB108:20~08:30 |
¹ÚÁ¤¿¬ ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Prevalence of gestational diabetes according to different oral glucose tolerance tests in the Korean population |
OB208:30~08:40 |
Á¶Èñ¿µ ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Association between gestational fasting plasma glucose and maternal and perinatal outcomes in gestational diabetes mellitus patients
|
OB308:40~08:50 |
ºÎÇý¿¬ ÇѾç´ëÇб³º´¿ø »êºÎÀΰú |
Nonlinear and linear indices of fetal heart rate in large for gestational age fetuses |
OB408:50~09:00 |
¾È±âÈÆ °í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú |
The Safety of Progesterone for Treatment of Preterm Labor: Meta-analysis |
OB5-OB8 (09:00~09:40) |
ÁÂÀå : ±è»çÁø(°¡Å縯ÀÇ´ë) |
OB509:00~09:10 |
Á¤Àº¿µ ¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú |
Àڱøñ¹«·ÂÁõ »ê¸ð¿¡¼ ÀÀ±Þ Àڱøñ¿øÇü¹À½¼ú ½ÃÇà ÈÄ ÇÁ·Î°Ô½ºÅ×·Ð Ãß°¡ Ä¡·áÀÇ Á¶»ê ¿¹¹æ È¿°ú |
OB609:10~09:20 |
ÀÌÇýÁ¤ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
Gestational age at delivery and neonatal outcome in uncomplicated twin pregnancies; what is the optimal age for delivery according to chorionicity? |
OB709:20~09:30 |
Á¶ÁÖÇö ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Should we adjust the cut-off value for 50g glucose challenge test(GCT) higher in twin pregnancy? |
OB809:30~09:40 |
Á¶±ÝÁØ °í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú |
Gestational diabetes and pre-pregnancy factors as long-term risk factors for developing diabetes mellitus |
OB9-OB12 (09:40~10:20) |
ÁÂÀå : ±è ¾Ï(¿ï»êÀÇ´ë) |
OB909:40~09:50 |
ÃÖ¼ö¶õ ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú |
Secretory Leukocyte Protease Inhibitor and Neutrophil Elastase in the cervical mucus with short cervical length |
OB1009:50~10:00 |
ÀÌÁØÈ£ ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Maternal vascular underperfusion: clinical implications in a preterm birth cohort |
OB1110:00~10:10 |
±è¹ÎÇü
|
Placental microRNAs as potential biomarkers for noninvasive detection of trisomy 21 |
OB1210:10~10:20 |
³ª¼ºÈÆ °¿ø´ëÇб³º´¿ø »êºÎÀΰú |
Expansion by basic fibroblast growth factor of non-enzymatically isolated perivascular cells from human umbilical cord
|
OB13-OB16 (11:00~11:40) |
ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë) |
OB1311:00~11:10 |
õÁÖ¿µ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Effects of ECM Protein Mimetics on Adhesion and Proliferation of Chorion Derived Mesenchymal Stem Cells |
OB1411:10~11:20 |
¾î°æÁø ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
A Prospective Study on the maternal serum PlGF and PAPP-A identified at the first trimester as parameters of subsequently developed pre-eclampsia and SGA |
OB1511:20~11:30 |
ÀÌû¾Æ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy |
OB1611:30~11:40 |
¹Ú¼¿¬ Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Analysis of global gene expression through the amniotic fluid cell-free fetal RNA according to the gestational
age |
OB17-OB20 (11:40~12:20) |
ÁÂÀå : ±è¼®¿µ(°¡ÃµÀÇ´ë) |
OB1711:40~11:50 |
±è¹Î¾Æ ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
The influence of disease activity on birth outcomes in women with irritable bowel disease: Meta-analysis |
OB1811:50~12:00 |
À±ÁÖÇö ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú |
Differential effect of food restriction during gestation or lactation period on changes in enzymes associated with hepatic lipid metabolism in male rat pups
|
OB1912:00~12:10 |
Á¤½Å¿Á
|
Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry for quantifying total NNAL in early pregnant women |
OB2012:10~12:20 |
ÇѼºÈñ (Àç)¼¿ïÀÇ°úÇבּ¸¼Ò |
Clinical application of noninvasive prenatal test (NIPT) for fetal chromosomal aneuploidy by maternal plasma DNA sequencing: The first experience in Korea |
OB21-OB24 (12:20~13:00) |
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë) |
OB2112:20~12:30 |
½É¼ÒÇö Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Mullerian anomaly°¡ ÀÖ´Â ¿©¼º¿¡¼ÀÇ ½ÖÅÂÀӽſ¡ °üÇÑ ¿¬±¸ |
OB2212:30~12:40 |
±ÇÁ¤Àº ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
»ïÅÂ¾Æ Àӽſ¡¼ ÀӽŹæ¹ý¿¡ µû¸¥ Á¢ÇÕ¼º°ú ÀӽŠÁß ÇÕº´ÁõÀÇ Â÷ÀÌ |
OB2312:40~12:50 |
±è¹Î¾Æ ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú |
35¼¼ ÀÌ»óÀÇ °í·É ½ÖÅÂÀÓ½ÅÀÇ ÁÖ»ê±â ¿¹ÈÄ |
OB2412:50~13:00 |
¹ÚÇö¼ö µ¿±¹ÀÇ´ë Àϻ꺴¿ø »êºÎÀΰú |
ȸÀ½Àý°³ÀÇ À¯¹«¿¡ µû¸¥ 3µµ ¿»ó ¹ß»ýÀÇ ºñ±³ |
OB25-OB29 (14:00~14:50) |
ÁÂÀå : ±è±¤ÁØ(Áß¾ÓÀÇ´ë) |
OB2514:00~14:10 |
¿°Á¤ÀÎ ¾ç»êºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú |
Differential expression of steroid hormone coactivators in the human placenta complicated with preeclampsia |
OB2614:10~14:20 |
¹ÚÁöÀº °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
Analysis of Increased Nuchal Translucency: Experience of a Single University Hospital |
OB2714:20~14:30 |
ÁøÇý¹Ì °í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú |
Maternal MgSO4 treatment during pregnancy does not affect offspring¡¯s bone |
OB2814:30~14:40 |
À̽ÂÇü °¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú |
Clinical profiles and outcomes in peripartum cardiomyopathy |
OB2914:40~14:50 |
¹ÚÁö±Ç °æ»ó´ëÇб³º´¿ø »êºÎÀΰú |
The modified Shirodkar procedure for rescue cervical cerclage: effective alternative to the McDonald suture |